Article
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Oct 2013
Rekhtman Natasha, Ang Daphne C, Riely Gregory J, Ladanyi Marc, Moreira Andre L
Abstract excerpt
KRAS mutations define a clinically distinct subgroup of lung adenocarcinoma patients, characterized by smoking history, resistance to EGFR-targeted therapies, and adverse prognosis. Whether KRAS-mutated lung adenocarcinomas also have distinct histopathological features is not well established. We tested 180 resected lung adenocarcinomas for KRAS and EGFR mutations by high-sensitivity mass spectrometry-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
